At Immunosolv, our wealth of novel reagents and experience in the field of cell-death and apoptosis research allows us to offer a tailor-made service in the design of sensitive cell death assays for new target discovery and for screening lead therapeutics. Our assay technologies can be applied across broad platforms to detect cells from the earliest stages of apoptosis to the latest stages of necrosis.